Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/8049 stock hub

HKG/8049 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/8049is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/8049

In the news

Latest news · HKG/8049

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E6.2

P25 10.7P50 17.9P75 38.5

ROE12

P25 -14.7P50 2P75 9.4

ROIC16.2

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/8049 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	1,107
Employees Change	362%
Employees Change Percent	48.59
Enterprise value	HKD 612.7M
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100000130
Last refreshed	2026-05-10
Market cap	HKD 1.4B
Price	HKD 2.46
Price currency	HKD
Rev Per Employee	906,602.59x
Sector	Healthcare
Sic	2834
Symbol	hkg/8049
Website	https://www.jlchanglong.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	16.06%
EV Earnings	2.77x
EV/EBIT	2.56x
EV/EBITDA	2.26x
EV/FCF	1.83x
EV/Sales	0.61x
FCF yield	24.29%
P/B ratio	0.73x
P/E ratio	6.23x
P/S ratio	1.37x
PE Ratio10 Y	4.14x
PE Ratio3 Y	5.07x
PE Ratio5 Y	4.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.89%
EBITDA Margin	26.9%
FCF margin	33.35%
Gross margin	84.01%
Gross Profit	HKD 843.1M
Gross Profit Growth	3.53%
Gross Profit Growth Q	6.98%
Gross Profit Growth3 Y	6.17%
Gross Profit Growth5 Y	4.22%
Net Income	HKD 221.3M
Net Income Growth	7.94%
Net Income Growth Q	19.9%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	5.03%
Net Income Growth5 Y	0.17%
Pretax Margin	29.32%
Profit Margin	22.05%
Profit Per Employee	HKD 199,928
Profitable Years	26
ROA	5.18
Roa5y	4.64
ROCE	12.46
ROE	11.99
Roe5y	11.26
ROIC	16.19
Roic5y	15.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.7%
Cagr15y	13.68%
Cagr1y	48.88%
Cagr20y	21.03%
Cagr3y	35.11%
Cagr5y	29.33%
Div CAGR10	12.26%
Div CAGR3	-20.99%
Div CAGR5	45.47%
EPS Growth	7.94
EPS Growth Q	19.9
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	5.03
EPS Growth5 Y	0.17
FCF Growth	44.18%
OCF Growth	42.61%
OCF Growth10 Y	7.55%
Revenue Growth	2.35x
Revenue Growth Q	-5.14x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	2.44x
Revenue Growth5 Y	0.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.35
Assets	HKD 3B
Cash	HKD 766M
Current Assets	HKD 1.4B
Current Liabilities	HKD 1.1B
Debt	HKD 445,124
Debt EBITDA	HKD 0
Debt Equity	HKD 0
Debt FCF	HKD 0
Equity	HKD 1.9B
Interest Coverage	155.3
Liabilities	HKD 1.1B
Long Term Assets	HKD 1.6B
Long Term Liabilities	HKD 7.8M
Net Cash	HKD 765.5M
Net Cash By Market Cap	HKD 55.54
Net Cash Growth	34.57%
Net Debt EBITDA	HKD -2.84
Net Debt Equity	HKD -0.41
Net Debt FCF	HKD -2.29
Tangible Book Value	HKD 1.9B
Tangible Book Value Per Share	HKD 3.34
WACC	5.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	2.13
Net Working Capital	HKD -454M
Quick ratio	1.2
Working Capital	HKD 311.5M
Working Capital Turnover	HKD 3.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	297.73%
Dividend Growth Years	1%
Dividend per share	HKD 0.27
Dividend Years	8
Dividend Yield	11.09%
Ex Div Date	2026-06-22
Last Dividend	HKD 0.27
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	230.36%
1Y total return	48.84%
200-day SMA	2.18
3Y total return	146.71%
50-day SMA	2.26
50-day SMA vs 200-day SMA	50over200
5Y total return	261.69%
All Time High	5.2
All Time High Change	-52.69%
All Time High Date	2015-04-09
All Time Low	0.07
All Time Low Change	3,539.05%
All Time Low Date	2004-11-08
ATR	0.06
Beta	0.29
Beta1y	0.16
Beta2y	0.27
Ch YTD	12.84
High	2.51
High52	2.6
High52 Date	2026-04-29
High52ch	-5.38%
Low	2.46
Low52	1.7
Low52 Date	2025-05-09
Low52ch	44.71%
Ma50ch	8.71%
Price vs 200-day SMA	12.84%
RSI	58.42
RSI Monthly	71.45
RSI Weekly	67.36
Sharpe ratio	1.15x
Sortino ratio	2.37
Total Return	11.09%
Tr YTD	12.84
Tr15y	583.9%
Tr1m	5.58%
Tr1w	-2.38%
Tr3m	20%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 239.7M
Operating Income Growth	19.26
Operating Income Growth Q	61.22
Operating Income Growth3 Y	5.91
Operating Income Growth5 Y	4.47
Operating margin	23.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	172,500,000%
Net Borrowing	-82,912,539.7
Shares Insiders	26.84%
Shares Institutions	0.01%
Shares Out	560,250,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 334.7M
Average Volume	69,400x
Bv Per Share	3.35
CAPEX	HKD -13.9M
Ch10y	45.56
Ch15y	196.4
Ch1m	5.58
Ch1w	-2.38
Ch1y	31.55
Ch20y	1,708.8
Ch3m	20
Ch3y	45.56
Ch5y	86.36
Ch6m	14.95
Change	-1.99%
Change From Open	-1.99
Close	2.51
Days Gap	0
Depreciation Amortization	31,339,788.4
Dollar Volume	78,720
Earnings Date	2026-08-14
EBIT	HKD 239.7M
EBITDA	HKD 270M
EPS	HKD 0.4
F Score	5
FCF	HKD 334.7M
FCF EV Yield	54.63x
FCF Per Share	HKD 0.6
Financing CF	-196,747,077
Fiscal Year End	December
Founded	1,989
Goodwill	7,201,875.3
Graham Number	5.45975
Graham Upside	121.9
Income Tax	HKD 73M
Investing CF	-255,041,642
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Lynch Fair Value	HKD 1.98
Lynch Upside	-19.71
Ma150	2.19
Ma150ch	12.43%
Ma20	2.44
Ma20ch	0.86%
Net CF	-103,208,699
Next Earnings Date	2026-08-14
Open	2.51
P FCF Ratio	4.12
P OCF Ratio	3.95
Payment Date	2025-07-18
Position In Range	0
Ppne	342,570,431.2
Price Date	2026-05-07
Price EBITDA	HKD 5.1
Ptbv Ratio	0.74
Relative Volume	0.46x
Revenue	1,003,609,066x
Tax By Revenue	7.27x
Tax Rate	24.8%
Tr20y	4,445.96%
Tr6m	14.95%
Volume	32,000
Z Score	2.18

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/8049 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+11.1%

$0.27 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+45.5%

1 consecutive years of growth

Total shareholder yield

+11.1%

Next ex-dividend date: 2026-06-22

Performance

HKG/8049 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/8049?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+26.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/8049 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.4

Neutral momentum band

Price vs 200-day MA

+12.8%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

1.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/8049

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/8049 stock rating?

hkg/8049 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/8049 analysis?

The full report lives at /stocks/hkg/8049/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/8049?

The latest report frames hkg/8049 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/8049 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.